NutriAsia Inc., a food company and the leading producer of condiment products in the Philippines announced on Wednesday that it plans to inoculate its employees for free.
According to NutriAsia, it will be giving free COVID-19 vaccines to its employees as well as their qualified dependents “to protect them and safeguard their good health.”
The company added that its vaccination plan would follow government regulations and guidelines.
“A staple on every Filipino table, NutriAsia and its brands are wholeheartedly committed to aid our national government in its pursuit to fight COVID-19 and its effects. We are choosing to proactively be part of the solution to end the worst public health crisis in a century with the decision to give our employees and three of their qualified dependents the option to be vaccinated against the COVID-19 virus,” said Joselito Campos Jr., chairman of NutriAsia.
“Knowing that family is at the heart of any person, we feel that extending the vaccination option to our employees’ dependents will give our people peace of mind with the assurance of their loved ones’ health and safety,” he added.
“This is important as our employees continue to help rebuild the economy through invaluable frontline work at NutriAsia by providing basic food products for their countrymen” he further said.
Also read: Metro Manila mayors to close gyms, spas, internet cafes for 2 weeks
NutriAsia plans to vaccinate employees for free
Last month, President Rodrigo Duterte signed the Vaccination Program Act of 2021 into law which allows the private sector, in cooperation with the Department of Health and the National Task Force Against COVID-19, to buy COVID-19 vaccines for their employees through a multiparty agreement.
In February, the private sector is already working to get a supply of Moderna and Novavax coronavirus disease (COVID-19) vaccines.
This is after it was announced that AstraZeneca no longer accepts vaccine orders.
The private sector has helped consolidate 8 million doses of Moderna vaccine, according to Presidential Adviser for Entrepreneurship Joey Concepcion.
About 800 companies participated in the briefing and showed interest in the Novavax vaccine, which is said to have an 88 to 89 percent efficacy rate.